@misc{indiciaee3f27a72696b,
  title = {Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs.},
  author = {R H Straub and U Müller-Ladner and T Lichtinger and J Schölmerich and H Menninger and B Lang},
  year = {1997},
  doi = {10.1093/rheumatology/36.12.1298},
  url = {https://pubmed.ncbi.nlm.nih.gov/9448591/},
  note = {Source identifier: 9448591}
}